This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Engel, L. S. Articles by Rothman, N. Search for Related Content PubMed PubMed Citation Articles by Engel, L. S. Articles by Rothman, N.

Polychlorinated Biphenyl Levels in Peripheral Blood and Non-Hodgkin's Lymphoma: A Report from Three Cohorts

¹ Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center; ² Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York; ³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; ⁴ Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; ⁵ Departments of Environmental Health and Epidemiology and ⁶ Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts; ⁷ The Norwegian Cancer Registry, Oslo, Norway; ⁸ Department of Environmental Health Sciences and ⁹ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and ¹⁰ National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Requests for reprints: Lawrence S. Engel, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street, 3rd Floor, New York, NY 10021. Phone: 646-735-8171; Fax: 646-735-0012; E-mail: engell{at}mskcc.org.

The incidence of non-Hodgkin's lymphoma (NHL) unrelated to HIV infection has steadily increased over the past several decades and remains substantially unexplained. Limited evidence suggests that increased concentrations of polychlorinated biphenyls (PCB) measured in blood or fat tissue are associated with increased risk of NHL. Although PCB congeners vary in their biological activity, the relation between individual congeners and NHL risk has not been examined previously using prospectively collected biospecimens. We examined congener-specific associations in three prospective cohorts. Prediagnostic serum or plasma concentrations of selected PCB congeners were measured among NHL cases and controls from these cohorts: Janus (190 cases and 190 controls) in Norway and CLUE I (74 cases and 147 controls) and the Nurses' Health Study (30 cases and 78 controls) in the United States. All blood samples were collected in the 1970s or 1980s. We used logistic regression to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for the relations between risk of NHL and lipid-corrected plasma or serum concentrations. Several congeners (i.e., 118, 138, and 153) that were present at higher levels and were moderately to highly correlated with each other showed exposure-response trends with risk of NHL in all three cohorts. These associations were observed primarily among subjects diagnosed closer to the date of blood collection in the two cohorts with sufficient cases to permit stratification by time. Among cases diagnosed within the median years of follow-up (16 years in Janus and 12 years in CLUE I), ORs and 95% CIs for increasing fourths of concentration of congener 118 relative to the lowest fourth were as follows: 2.4 (0.9–6.5), 4.9 (1.6–15.3), and 5.3 (1.5–18.8; P_trend < 0.005) in Janus and 8.1 (1.0–68.9), 6.6 (0.7–59.0), and 13.0 (1.6–106.8; P_trend < 0.05) in CLUE I. Similar patterns were seen for congeners 138 and 153 and for total PCBs. Limited evidence of exposure-response trends was also observed for several other congeners. The primary 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane metabolite, p,p'-DDE, was not significantly associated with NHL in most analyses but slightly to moderately confounded the PCB associations. The results from these three cohorts suggest that concentrations of certain PCBs in blood are associated with increased risk of NHL. [Cancer Res 2007;67(11):5545–52]

This article has been cited by other articles:

				J. S. Colt, N. Rothman, R. K. Severson, P. Hartge, J. R. Cerhan, N. Chatterjee, W. Cozen, L. M. Morton, A. J. De Roos, S. Davis, et al. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma Blood, February 26, 2009; 113(9): 1899 - 1905. [Abstract] [Full Text] [PDF]

				P. Vineis and W. Xun The emerging epidemic of environmental cancers in developing countries Ann. Onc., February 1, 2009; 20(2): 205 - 212. [Abstract] [Full Text] [PDF]

				T. T. Vo, B. C. Gladen, G. S. Cooper, D. D. Baird, J. L. Daniels, M. D. Gammon, and D. B. Richardson Dichlorodiphenyldichloroethane and Polychlorinated Biphenyls: Intraindividual Changes, Correlations, and Predictors in Healthy Women from the Southeastern United States Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2729 - 2736. [Abstract] [Full Text] [PDF]

				Honors and Awards * Bibliography of Peer-Reviewed Journal Articles Am. J. Epidemiol., October 1, 2008; 168(7): 845 - 854. [Full Text] [PDF]

				D. Schneider, M. A. Manzan, R. B. Crawford, W. Chen, and N. E. Kaminski 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Impairment of B Cell Differentiation Involves Dysregulation of Paired Box 5 (Pax5) Isoform, Pax5a J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 463 - 474. [Abstract] [Full Text] [PDF]

				P Cocco, P Brennan, A Ibba, S de Sanjose Llongueras, M Maynadie, A Nieters, N Becker, M G Ennas, M G Tocco, and P Boffetta Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes Occup. Environ. Med., February 1, 2008; 65(2): 132 - 140. [Abstract] [Full Text] [PDF]